Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 955-964

  Gorzalka, Simone ^a   Vittori, Sauro ^b   Volpini, Rosaria ^b   Cristalli, Gloria ^b   Von Kügelgen, Ivar ^a   Müller, Christa E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEAZAADENOSINE; 1 METHYLADENINE; 2 CHLOROADENINE; 2 FLUOROADENINE; 3 DEAZAADENOSINE; 3 METHYLADENINE; 7 ETHYLADENINE; 7 METHYLADENINE; 8 BROMOADENINE; 8 THIOADENINE; 9 DIHYDROXYPROPYLADENINE; 9 ETHYLADENINE; 9 METHYLADENINE; ADENINE DERIVATIVE; ADENINE RECEPTOR; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CAFFEINE; FORSKOLIN; N 6 BENZOYLADENINE; N 6 BENZYLADENINE; N 6 DIMETHYLADENINE; N 6 METHYLADENINE; PURINE RECEPTOR; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZEATIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INHIBITION; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; NUCLEIC ACID STRUCTURE; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

ADENINE; ANIMALS; BRAIN; CELL LINE, TUMOR; CELL MEMBRANE; CORPUS STRIATUM; CYCLIC AMP; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); KINETICS; RATS; RECEPTORS, PURINERGIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 14944378002     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006601     Document Type: Article

References (29)

1. Bender E, Buist A, Jurzak M, Langlois X, Baggerman G, Verhasselt P, Ercken M, Guo H.-Q, Wintmolders C, Van den Wyngaert I, et al. (2002) Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc Natl Acad Sci USA 99:8573-8578.
2. Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz KN, and Cristalli G (1998) New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg Med Chem 6:523-533.
3. 2A receptor as an attractive target for Parkinson's disease treatment. Drug News Perspect 16:597-604.
4. Cristalli G, Franchetti P, Grifantini M, Vittori S, Bordoni T, and Geroni C (1987) Improved synthesis and antitumor activity of 1-deazaadenosine. J Med Chem 30:1686-1688.
5. De Koning H and Diallinas G (2000) Nucleobase transporters. Mol Membr Biol 17:75-94.
6. Dessauer CW, Tesmer JJG, Sprang SR, and Gilman AG (1999) The interactions of adenylate cyclases with P-site inhibitors. Trends Pharmacol Sci 20:205-210.
7. A receptors in human astrocytoma 1321N1 cells and screening of potential ligands. Pharmacology, in press.
8. Hughes AR, Martin MW, and Harden TK (1984) Pertussis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptors. Proc Natl Acad Sci USA 81:5680-5684.
9. Kaulich M, Qurishi R, and Müller CE (2003) Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis. Cell Mol Neurobiol 23:349-364.
10. Kelly MDW, Hill RG, Borsodi A, Toth G, and Kitchen I (1998) Weaning-induced development of D-opioid receptors in rat brain: differential effects of guanine nucleotides and sodium upon ligand-receptor recognition. Br J Pharmacol 125:979-986.
11. Klotz KN, Kachler S, Lambertucci C, Vittori S, Volpini R, and Cristalli G (2003) Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities. Naunyn-Schmiedeberg's Arch Pharmacol 367:629-634.
12. Kurose H, Katada T, Haga T, Haga K, Ichiyama A, and Ui M (1986) Functional interactions of purified muscarinic receptors with purified inhibitory guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J Biol Chem 261:6423-6428.
13. Levy DE, Bao M, Cherbavaz DB, Tomlinson JE, Sedlock DM, Homcy CJ, and Scarborough RM (2003) Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists. J Med Chem 46:2177-2186.
14. Lloyd HG and Stone TW (1985) Cyclohexyladenosine binding in rat striatum. Brain Res 334:385-388.
15. Lorenzen A, Grossekatthofer B, Kerst B, Vogt H, Fein T, and Schwabe U (1996) Characterization of a novel adenosine binding protein sensitive to cyclo-AMP in rat brain cytosolic and particulate fractions. Biochem Pharmacol 52:1375-1385.
16. 3H]adenosine from bovine cerebral cortex. J Neurochem 60:745-751.
17. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275.
18. Mattia C and Coluzzi F (2003) Antidepressants in chronic neuropathic pain. Mini Rev Med Chem 3:773-784.
19. Müller CE (2000) Adenosine receptor ligands - recent developments. Part. 1. Agonists. Curr Med Chem 7:1269-1288.
20. Müller CE, Schumacher B, Brattström A, Abourashed EA, and Koetter U (2002) Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 71:1939-1949.
21. 6-cyclohexyladenosine. Brain Res 237:203-214.
22. Redzic ZB, Segal MB, Gasic JM, Markovic ID, Vojvodic VP, Isakovic A, Thomas SA, and Rakic LM (2001) The characteristics of nucleobase transport and metabolism by the perfused sheep choroids plexus. Brain Res 888:66-74.
23. 1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt and solubilization. J Neurochem 51:1592-1598.
24. 2B adenosine receptors. Curr Top Med Chem 3:427-443.
25. Watanabe S, Yoshimi Y, and Ikekita M (2003) Neuroprotective effect of adenine on Purkinje cell survival in rat cerebellar primary cultures. J Neurosci Res 74:754-759.
26. Yamane HK and Fung BKK (1993) Covalent modifications of G-proteins. Annu Rev Pharmacol Toxicol 32:201-241.
27. Yeung SH and Green RD (1983) Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5′- guanylylimidodiphosphate or N-ethylmaleimide. J Biol Chem 258:2234-2239.
28. Yoshimi Y, Watanabe S, Shinomiya T, Makino A, Toyoda M, and Ikekita M (2003) Nucleobase adenine as a trophic factor acting on Purkinje cells. Brain Res 991:113-122.
29. Yoshioka K, Matsuda A, and Nakata H (2001) Pharmacology of a unique adenosine binding site in rat brain using a selective ligand. Clin Exp Pharmacol Physiol 28:278-284.